ArticleOPEN ACCESS

Prolonged Remissions after Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

HemaSphere
DOI: 10.1097/HS9.0000000000000672
5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Houot, R., Poeschel, V., Altmann, B., Angel, S., Thurner, L., Illmer, T., … Held, G. (2022, February 10). Prolonged Remissions after Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. HemaSphere. Wolters Kluwer Health. https://doi.org/10.1097/HS9.0000000000000672

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free